Bevacizumab for recurrent ependymoma.

Neurology
R M GreenA B Lassman

Abstract

Ependymoma is a rare type of glioma, representing 5% of all CNS malignancies. Radiotherapy (RT) is commonly administered, but there is no standard chemotherapy. At recurrence, ependymoma is notoriously refractory to therapy and the prognosis is poor. In recurrent glioblastoma, encouraging responses with bevacizumab have been observed. In this Institutional Review Board-approved study, we retrospectively analyzed the records of 8 adult patients treated for recurrent ependymoma and anaplastic ependymoma with bevacizumab containing chemotherapy regimens. We determined radiographic response (Macdonald criteria), median time to progression (TTP), and median overall survival (OS; Kaplan-Meier method). There were 4 men and 4 women with a median age of 40 years (range, 20-65). Prior treatment included surgery (n = 8), RT (8), temozolomide (5), and carboplatin (4). Bevacizumab (5-15 mg/kg every 2-3 weeks) was administered alone (2) or concurrently with cytotoxic chemotherapy including irinotecan (3), carboplatin (2), or temozolomide (1). Six patients achieved a partial response (75%) and 1 remained stable for over 8 months. Median TTP was 6.4 months (95% confidence interval 1.4-7.4) and median OS was 9.4 months (95% confidence interval ...Continue Reading

Citations

Apr 29, 2010·Current Neurology and Neuroscience Reports·Mark R GilbertRiccardo Soffietti
Feb 18, 2011·Current Neurology and Neuroscience Reports·Marc C Chamberlain, Trent L Tredway
Aug 27, 2013·Clinical Oncology : a Journal of the Royal College of Radiologists·Muhammad Shahid Iqbal, Joanne Lewis
Sep 6, 2011·Current Opinion in Oncology·Jacques GrillCéline Ferreira
May 24, 2011·Clinical Medicine Insights. Oncology·Marc C Chamberlain
Nov 6, 2013·Pathology Oncology Research : POR·József VirágBalázs Hegedűs
Sep 15, 2012·Pediatric Blood & Cancer·Cheryl FischerYasmin Khakoo
Feb 8, 2011·Pediatric Blood & Cancer·Toshihisa TsurutaYoshikazu Okada
Sep 16, 2015·Acta Neurologica Scandinavica·S FarschtschiV F Mautner
Apr 25, 2016·BMC Cancer·Dorothee GramatzkiMichael Weller
Dec 2, 2017·Neuro-oncology·Roberta RudàElizabeth Cohen-Jonathan Moyal
Apr 29, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C ShuJ Wang
Nov 2, 2014·Neuro-oncology·David SchiffPatrick Y Wen
Nov 9, 2012·Journal of Neuro-oncology·Lucas MorenoStergios Zacharoulis
Dec 24, 2011·Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences·P RajappaJeffrey P Greenfield
Dec 28, 2017·Acta neurochirurgica·N SvobodaV Benes
Jun 9, 2012·Journal of Neuro-oncology·Thomas J KaleyIgor T Gavrilovic
Nov 3, 2016·Journal of Neuro-oncology·Ethan A WinklerMichael W McDermott
Feb 2, 2021·Continuum : Lifelong Learning in Neurology·Amy A Pruitt
Feb 3, 2021·The Neuroradiology Journal·Marco VarrassiCarlo Masciocchi
Jul 20, 2021·Neuro-oncology Practice·Dorothee GramatzkiMichael Weller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Neurosurgery. Pediatrics
Michiel WagemakersWilfred F A den Dunnen
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
P SchüllerN Willich
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Piergiorgio ModenaGabriella Sozzi
Current Opinion in Neurology
Roberta RudaR Soffietti
© 2022 Meta ULC. All rights reserved